M Edip Gurol Selected Research

Cerebral Amyloid Angiopathy (Congophilic Angiopathy)

1/2022	Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
1/2022	The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
1/2022	Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.
1/2022	Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors.
1/2021	Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage.
1/2021	A practical approach to the management of cerebral amyloid angiopathy.
10/2019	Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.
1/2019	Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study.
1/2019	APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.
1/2019	Cortical Superficial Siderosis Evolution.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Edip Gurol Research Topics

Disease

21	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 11/2004
17	Cerebral Hemorrhage 01/2022 - 11/2013
9	Stroke (Strokes) 11/2021 - 03/2012
8	Atrial Fibrillation 01/2021 - 05/2016
6	Ischemic Stroke 10/2021 - 05/2016
6	Hemorrhage 08/2020 - 11/2008
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 08/2015
4	Hemorrhagic Stroke 08/2020 - 01/2019
4	Hematoma 01/2018 - 10/2016
4	Familial Cerebral Amyloid Angiopathy 02/2017 - 11/2008
3	Dementia (Dementias) 12/2021 - 07/2012
3	Siderosis 01/2020 - 01/2018
3	Cognitive Dysfunction 11/2013 - 11/2004
2	App-Related Cerebroarterial Amyloidosis 01/2022 - 10/2019
2	Brain Injuries (Brain Injury) 01/2022 - 11/2013
2	Leukoencephalopathies 01/2022 - 04/2013
2	Embolic Stroke 10/2021 - 11/2018
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 05/2016
2	Disease Progression 01/2019 - 10/2016
2	Atrophy 01/2018 - 01/2016
2	Leukoaraiosis 08/2014 - 04/2013
2	Alzheimer Disease (Alzheimer's Disease) 04/2013 - 11/2008
1	Hypertension (High Blood Pressure) 01/2022
1	Cerebral Small Vessel Diseases 12/2021
1	Thromboembolism 01/2020
1	Amyloid Plaque 10/2019
1	Gout 01/2019
1	Inflammation (Inflammations) 01/2019
1	Patent Foramen Ovale 05/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Lacunar Stroke 01/2018
1	Vascular System Injuries 07/2017
1	Amyloidosis 02/2017
1	Hypocalcemia 11/2016
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2016
1	Cerebral Cortical Thinning 01/2016
1	Infarction (Infarctions) 11/2013
1	Brain Ischemia (Cerebral Ischemia) 04/2013

Drug/Important Bio-Agent (IBA)

17	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2004
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
5	AnticoagulantsIBA 01/2021 - 05/2016
4	Apolipoproteins E (ApoE)IBA 12/2021 - 08/2016
4	ApolipoproteinsIBA 08/2020 - 04/2013
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 11/2008
2	Biological ProductsIBA 01/2022 - 12/2021
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 08/2016
2	oxidized low density lipoproteinIBA 01/2019 - 08/2016
2	LipidsIBA 01/2019 - 08/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 08/2015
2	CholesterolIBA 01/2018 - 08/2016
2	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 10/2016
2	Amyloid beta-PeptidesIBA 11/2008 - 07/2006
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2020
1	Uric Acid (Urate)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Vitamin K FDA Link 05/2018
1	CreatinineIBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 07/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	florbetapirIBA 11/2016
1	CalciumIBA 11/2016
1	Lipoproteins (Lipoprotein)IBA 08/2015
1	HemosiderinIBA 12/2013
1	danaparoid (Orgaran)FDA Link 03/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 05/2016
4	Secondary Prevention 11/2021 - 08/2015
1	Glycemic Control 05/2018
1	Withholding Treatment 03/2012